Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2023
Zinzino group revenue increased with a total of 24 %, compared with the previous year.
The revenue in November for Zinzino's sales markets increased by 24 % and amounted to SEK 199.6 (161.2) million. Faun Pharma's external sales increased by 29 % and amounted to SEK 7.6 (5.9) million. Overall, the Group increased revenues by 24 % to SEK 207.2 (167.1) million compared with the previous year.
Accumulated revenue for January - November 2023 increased by 22 % to SEK 1609.6 (1314.2) million.
Revenues were distributed as follows:
Regions,MSEK 23 22 Change YTD 2023 YTD 2022 Change
-Nov -Nov
The Nordics 29.3 28.4 3% 274.9 292.3 -6%
Central 50.9 38.6 32% 399.7 263,0 52%
Europe
East Europe 49.8 46.1 8% 362.3 314.2 15%
South & West 34.5 19.6 76% 241,0 149.7 61%
Europe
The Baltics 14.8 11.1 33% 91.7 70.7 30%
North 12.6 8,0 58% 97.5 71.6 36%
America
Asia-Pacific 6.2 7.9 -22% 45.8 71.7 -36%
Africa 1.5 1.5 0% 11.7 8.8 33%
Zinzino 199.6 161.2 24% 1524.6 1 242,0 23%
Faun Pharma 7.6 5.9 29% 85,0 72.2 18%
Zinzino 207.2 167.1 24% 1609.6 1314.2 22%
Group
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser:
Carnegie Investment Bank AB (publ)